Szilárd Tóth

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents

Ádám Póti, Hella Gyergyák, Eszter Németh et al. · Genome biology · 2019 · 118 citations · Full text

Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance

Veronika F.S. Pape, Szilárd Tóth, András Füredi et al. · European Journal of Medicinal Chemistry · 2016 · 105 citations

Medicinal Chemistry, Biochemistry, Medicine +11

Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer

András Füredi, Kornélia Szebényi, Szilárd Tóth et al. · Journal of Controlled Release · 2017 · 92 citations

Health Sciences, Polymer-drug Conjugate, Medicine +10

NGR-peptide−drug conjugates with dual targeting properties

Kata Nóra Enyedi, Szilárd Tóth, Gergely Szakács et al. · PLoS ONE · 2017 · 44 citations · Full text

Medicinal Chemistry, Medicine, Drug Discovery +12

High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones

Sonja Hager, Veronika F.S. Pape, Vivien Pósa et al. · Antioxidants and Redox Signaling · 2020 · 44 citations